Liposomal lurtotecan (NX211): Determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography

2000-01-28

Additional Metadata
Keywords	Lurtotecan
Persistent URL	dx.doi.org/10.1016/S0378-4347(99)00513-7, hdl.handle.net/1765/65874
Journal	Journal of Chromatography B: Biomedical Sciences and Applications
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Loos, W.J, Kehrer, D.F.S, Brouwer, E, Verweij, J, de Bruijn, P.J, Hamilton, M, … Sparreboom, A. (2000). Liposomal lurtotecan (NX211): Determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 738(1), 155–163. doi:10.1016/S0378-4347(99)00513-7

Publication